Loading
PharmaCielo Ltd. Stock: price and insider trades · Canada
PharmaCielo Ltd.: what insiders have been doing
PharmaCielo Ltd. is a Health Care company. Its directors and officers file their transactions with SEDI. In the past year (23 October 2025 to 23 October 2026), 12 filings came from 2 insiders.
On the market, 2 insiders bought (10 purchases totalling €66k) while 2 insiders sold (2 sales totalling €45k). Netting one side against the other leaves €21k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 2 senior executives. Biggest ticket of the year: €43k, sold by Lustig, Marc and made public on 24 September 2026.
The most recent open-market purchase was published on 16 October 2026, 7 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. The shorter that gap, the sooner other investors can see what insiders have done.
Compared with its exchange (2,472 companies, median 13 filings), a count of 12 filings is below the norm. The full history, which starts in 2022, counts 71 purchases against 8 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
105
Thresholds
n/a
Buy Volume
€678,775
71 ops. · all time
Sell Volume
€130,838
8 ops. · all time
Who traded when
BuySaleMarc Lustig10 buys1 sale
Douglas Bache7 buys1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
CA$0.05
Analyst consensus
Income statement
RevenueCA$2.5M
Gross profitCA$725.2k29% margin
EBITDA-CA$440.6k-17% margin
Net income-CA$3.6M-103.1% margin
Valuation
Beta0.62
Balance sheet & cash
Market capCA$11.1M
Total debtCA$18.2M
Free Cash Flow-CA$4.6M
Profitability & ownership
ROA-12.7%
% insiders13.1%
% institutions0.1%
Last declaration on 16 October 2026
Declarations105 total
134,000 shares@ CA$0.060.073% mcap12.9% of flowCommon SharesTSXSEDI:4792267
Canonical exit: 14 Jan 2027 (T+90)
266,000 shares@ CA$0.0550.13% mcap23.4% of flowCommon SharesTSXSEDI:4792266
Canonical exit: 14 Jan 2027 (T+90)
41,000 shares@ CA$0.0550.017% mcap5.6% of flowCommon SharesTSXSEDI:4790231
Canonical exit: 7 Jan 2027 (T+90)
350,000 shares@ CA$0.060.16% mcap55.6% of flowCommon SharesTSXSEDI:4789591
Canonical exit: 6 Jan 2027 (T+90)
50,000 shares@ CA$0.060.023% mcap7.9% of flowCommon SharesTSXSEDI:4789590
Canonical exit: 5 Jan 2027 (T+90)
72,000 shares@ CA$0.0550.030% mcap10.5% of flowCommon SharesTSXSEDI:4789589
Canonical exit: 5 Jan 2027 (T+90)
100,000 shares@ CA$0.060.045% mcap15.9% of flowCommon SharesTSXSEDI:4789588
Canonical exit: 3 Jan 2027 (T+90)
349,276 shares@ CA$0.185Common SharesTSXSEDI:4781392
70,000 shares@ CA$0.055100.0% of flowCommon SharesTSXSEDI:4771275
300,000 shares@ CA$0.1133Common SharesTSXSEDI:4629507
Canonical exit: 19 Nov 2023 (T+90)
50,000 shares@ CA$0.15Common SharesTSXSEDI:4629508
Canonical exit: 23 Nov 2023 (T+90)
14,000 shares@ CA$0.1143Common SharesTSXSEDI:4629509
Canonical exit: 23 Nov 2023 (T+90)
845,324 shares@ CA$0.20522.5% of flowCommon SharesTSXSEDI:4594820
Canonical exit: 23 Mar 2023 (T+90)
50,000 shares@ CA$0.43133.0% of flowCommon SharesTSXSEDI:4594822
Canonical exit: 12 Feb 2023 (T+90)
100,000 shares@ CA$0.41585.8% of flowCommon SharesTSXSEDI:4594825
Canonical exit: 9 Feb 2023 (T+90)
544,000 shares@ CA$0.1610.9% of flowCommon SharesTSXSEDI:4594840
112,800 shares@ CA$0.16512.3% of flowCommon SharesTSXSEDI:4594839
Canonical exit: 25 Dec 2024 (T+90)
75,000 shares@ CA$0.1151.1% of flowCommon SharesTSXSEDI:4594841
Canonical exit: 15 Dec 2024 (T+90)
75,000 shares@ CA$0.1051.0% of flowCommon SharesTSXSEDI:4594850
Canonical exit: 12 Dec 2024 (T+90)
10,000 shares@ CA$0.160.2% of flowCommon SharesTSXSEDI:4594852
Canonical exit: 3 Jun 2024 (T+90)
50,000 shares@ CA$0.171.1% of flowCommon SharesTSXSEDI:4594854
Canonical exit: 29 May 2024 (T+90)
100,000 shares@ CA$0.1692.2% of flowCommon SharesTSXSEDI:4594856
Canonical exit: 28 May 2024 (T+90)
75,000 shares@ CA$0.1771.7% of flowCommon SharesTSXSEDI:4594857
Canonical exit: 26 May 2024 (T+90)
35,000 shares@ CA$0.180.8% of flowCommon SharesTSXSEDI:4594858
Canonical exit: 23 May 2024 (T+90)
10,000 shares@ CA$0.1850.2% of flowCommon SharesTSXSEDI:4594860
Canonical exit: 22 May 2024 (T+90)
25 of 105 declarations
About PharmaCielo Ltd.
PharmaCielo Ltd. is a Canadian company focused on the production of medical cannabis. It is listed on the Toronto Stock Exchange under the symbol XTSE.
